Cagrilintide 10mg – 3ml Vial

Short Description

Cagrilintide (10mg) is a long-acting synthetic amylin analogue studied in controlled laboratory environments for its interaction with amylin and calcitonin receptor complexes and associated metabolic signalling pathways. Supplied as a high-purity lyophilised peptide in a sterile 3ml vial. For research use only.

Product Overview

Cagrilintide is a modified, long-acting analogue of the endogenous hormone amylin. It is designed for extended receptor interaction in experimental research models involving amylin receptor complexes (AMY receptors) and calcitonin receptor family signalling.

In vitro and pre-clinical laboratory studies commonly investigate Cagrilintide for:

• Amylin receptor binding dynamics

• Calcitonin receptor modulation

• Gastric signalling pathway mechanisms

• Central metabolic pathway signalling models

• Hormone–receptor interaction kinetics

Due to its structural modifications, Cagrilintide demonstrates prolonged receptor activity in controlled research systems compared to native amylin.

This compound is supplied as a lyophilised research-grade peptide to preserve stability and structural integrity prior to reconstitution.

Key Features

• Long-acting synthetic amylin analogue

• Studied in amylin and calcitonin receptor research

• Investigated in metabolic signalling pathway models

• Structural modifications for extended receptor interaction

• ≥99% purity (HPLC verified)

• Lyophilised for enhanced stability

• 10mg per sterile 3ml glass vial

Product Specifications

• Product Name: Cagrilintide

• Synonyms: Long-Acting Amylin Analogue; Amylin Receptor Agonist Analogue

• Molecular Class: Synthetic peptide analogue

• Amino Acid Sequence (3-Letter Code):
  Modified amylin analogue containing structural substitutions and a disulfide bridge (full proprietary analogue sequence available within formal research documentation)

• Molecular Formula: C194H317N55O59

• Molecular Weight: ~4100 g/mol (approximate)

• CAS Number: 1415456-99-3

• Purity: ≥99% (HPLC)

• Appearance: White to off-white lyophilised solid

• Net Content: 10mg

• Vial Size: 3ml sterile glass vial

• Storage Form: Lyophilised peptide

• Intended Use: Laboratory research only

Handling & Storage Guidelines

Unreconstituted (Lyophilised) Storage:
Store at −20°C for long-term preservation. Short-term storage at 2–8°C is acceptable if intended for use within 1–3 months.

Reconstituted Storage:
After reconstitution, store at 2–8°C and use within 3–6 weeks. Stability may vary depending on solvent selection and handling conditions.

Avoid repeated freeze–thaw cycles. Protect from excessive agitation, heat, and direct light exposure.

Manufacturing & Quality

Cagrilintide is manufactured using advanced peptide synthesis techniques under GMP-aligned laboratory conditions.

Each batch undergoes:

• High Performance Liquid Chromatography (HPLC) purity verification

• Mass spectrometry identity confirmation

• Analytical quality control prior to release

• Batch traceability and documentation procedures

Products are released only after meeting strict internal quality specifications.

Legal & Safety Notice

This product is supplied strictly for laboratory research purposes only.

Not for human consumption.
Not for therapeutic, diagnostic, or veterinary use.
Not a licensed medicinal product in the United Kingdom.

The purchaser is responsible for ensuring full compliance with all applicable UK laws and regulations relating to research chemicals.